Author:
Lidgren Mathias,Wilking Nils,Jönsson Bengt,Rehnberg Clas
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference34 articles.
1. The National Board of Health, Welfare. (2005). Cancer Incidence in Sweden 2004. Stockholm: Official Statistics of Sweden.
2. The National Board of Health and Welfare. (2005). Causes of death 2003. Stockholm: Official Statistics of Sweden.
3. Slamon, D. J., Leyland-Jones, B., Shak, S., et al. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. The New England Journal of Medicine, 344(11), 783–792.
4. Bishop, J. F., Dewar, J., Toner, G. C., et al. (1999). Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. Journal of Clinical Oncology, 17(8), 2355–2364.
5. Chan, S., Friedrichs, K., Noel, D., et al. (1999). Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. Journal of Clinical Oncology, 17(8), 2341–2354.
Cited by
180 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献